Novel 3,6-Disubstituted Pyridazine Derivatives Targeting JNK1 Pathway: Scaffold Hopping and Hybridization-Based Design, Synthesis, Molecular Modeling, and In Vitro and In Vivo Anticancer Evaluation
Open Access
- 19 August 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (35) , 37310-37329
Abstract
A series of novel 3,6-disubstituted pyridazine derivatives were designed, synthesized, and biologically evaluated as preclinical anticancer candidates. Compound 9e exhibited the highest growth inhibition against most of the NCI-60 cancer cell lines. The in vivo anticancer activity of 9e was subsequently investigated at two dose levels using the Ehrlich ascites carcinoma solid tumor animal model, where a reduction in the mean tumor volume allied with necrosis induction was reported without any signs of toxicity in the treated groups. Interestingly, compound 9e was capable of downregulating c-jun N-terminal kinase-1 (JNK1) gene expression and curbing the protein levels of its phosphorylated form, in parallel with a reduction in its downstream targets, namely, c-Jun and c-Fos in tumors, along with restoring p53 activity. Furthermore, molecular docking and dynamics simulations were carried out to predict the binding mode of 9e and prove its stability in the JNK1 binding pocket.Keywords
This publication has 79 references indexed in Scilit:
- Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase−Positive Non–Small Cell Lung CancerJAMA Oncology, 2021
- JNK signaling in cancer cell survivalMedicinal Research Reviews, 2019
- Small-Molecule Library Screening by Docking with PyRx2014
- FRED and HYBRID docking performance on standardized datasetsJournal of Computer-Aided Molecular Design, 2012
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Comparing protein–ligand docking programs is difficultProteins: Structure, Function, and Bioinformatics, 2005
- Development and testing of a general amber force fieldJournal of Computational Chemistry, 2004
- Investigations of New Pyridazinone Derivatives for the Synthesis of Potent Analgesic and Anti‐Inflammatory Compounds with Cyclooxygenase Inhibitory ActivityArchiv der Pharmazie, 2003
- Activation and inhibition of the AP-1 complex in human breast cancer cellsMolecular Carcinogenesis, 1996